Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keller, J. N.
Right arrow Articles by Markesbery, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keller, J. N.
Right arrow Articles by Markesbery, W. R.
Related Collections
Right arrow Alzheimer's disease
Right arrow MCI (mild cognitive impairment)
NEUROLOGY 2005;64:1152-1156
© 2005 American Academy of Neurology

Evidence of increased oxidative damage in subjects with mild cognitive impairment

J. N. Keller, PhD, F. A. Schmitt, PhD, S. W. Scheff, PhD, Q. Ding, PhD, Q. Chen, PhD, D. A. Butterfield, PhD and W. R. Markesbery, MD

From the Departments of Anatomy and Neurobiology (Drs. Keller, Scheff, and Ding), Chemistry (Dr. Butterfield), and Pathology and Neurology (Dr. Markesbery), and Sanders-Brown Center on Aging (Drs. Keller, Schmitt, Scheff, Chen, Butterfield, and Markesbery), University of Kentucky, Lexington.

Address correspondence and reprint requests to Dr. Jeffrey N. Keller, 205 Sanders-Brown Center on Aging, 800 South Limestone, University of Kentucky, Lexington, KY 40536-0230; e-mail: Jnkell0{at}pop.uky.edu

Objective: To determine if increased levels of oxidative damage are present in the brains of persons with mild cognitive impairment (MCI), a condition that often precedes Alzheimer disease (AD).

Methods: The authors assessed the amount of protein carbonyls, thiobarbituric acid-reactive substances (TBARS), and malondialdehyde in the superior and middle temporal gyri (SMTG) and cerebellum of short postmortem interval and longitudinally evaluated normal subjects and those with MCI and early AD.

Results: Elevated levels of protein carbonyls (~25%), malondialdehyde (~60%), and TBARS (~210%) were observed in the SMTG of individuals with MCI and early AD vs normal control subjects. The elevation in TBARS was associated with the numbers of neuritic but not diffuse plaques. Levels of protein carbonyls increased as delayed verbal memory performance declined.

Conclusion: Oxidative damage occurs in the brain of subjects with mild cognitive impairment, suggesting that oxidative damage may be one of the earliest events in the onset and progression of Alzheimer disease.

Supported by NIH grants (AG018437, 5P01-AG005119, 5P50-AG05114), and grants from the Hereditary Disease Foundation and the Abercrombie Foundation.

Received September 1, 2004. Accepted in final form December 2, 2004.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
K. W. Park, H. H. Baik, and B. K. Jin
IL-13-Induced Oxidative Stress via Microglial NADPH Oxidase Contributes to Death of Hippocampal Neurons In Vivo
J. Immunol., October 1, 2009; 183(7): 4666 - 4674.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. Dumont, E. Wille, C. Stack, N. Y. Calingasan, M. F. Beal, and M. T. Lin
Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease
FASEB J, August 1, 2009; 23(8): 2459 - 2466.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
N. Scarmeas, Y. Stern, R. Mayeux, J. J. Manly, N. Schupf, and J. A. Luchsinger
Mediterranean Diet and Mild Cognitive Impairment
Arch Neurol, February 1, 2009; 66(2): 216 - 225.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. A. Maki, V. A. Tyurin, R. C. Lyon, R. L. Hamilton, S. T. DeKosky, V. E. Kagan, and W. F. Reynolds
Aberrant Expression of Myeloperoxidase in Astrocytes Promotes Phospholipid Oxidation and Memory Deficits in a Mouse Model of Alzheimer Disease
J. Biol. Chem., January 30, 2009; 284(5): 3158 - 3169.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
W.-Y. Lin, R. M. Levin, P. Chichester, R. Leggett, Y.-S. Juan, A. Johnson, P. Neumann, C. Whitbeck, A. Guven, B. Kogan, et al.
Effects of L-arginine and L-NAME on chronic partial bladder outlet obstruction in rabbit
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2390 - R2399.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
W. R. Markesbery and M. A. Lovell
Damage to Lipids, Proteins, DNA, and RNA in Mild Cognitive Impairment
Arch Neurol, July 1, 2007; 64(7): 954 - 956.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. W. Scheff, D. A. Price, F. A. Schmitt, S. T. DeKosky, and E. J. Mufson
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
Neurology, May 1, 2007; 68(18): 1501 - 1508.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. S. Forman, E. J. Mufson, S. Leurgans, D. Pratico, S. Joyce, S. Leight, V. M.-Y. Lee, and J. Q. Trojanowski
Cortical biochemistry in MCI and Alzheimer disease: Lack of correlation with clinical diagnosis
Neurology, March 6, 2007; 68(10): 757 - 763.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
Q. Ding, W. R. Markesbery, Q. Chen, F. Li, and J. N. Keller
Ribosome Dysfunction Is an Early Event in Alzheimer's Disease
J. Neurosci., October 5, 2005; 25(40): 9171 - 9175.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.